Lostam BioPharmaceuticals

Treatment for Bacterial Infections

Health Tech & Life Sciences
Non Active, Aug 2016
Pre-Funding Nazareth, Israel Founded 2009
LinkedIn
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2009
Headcount
500+
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences

About

Lostam BioPharmaceuticals is developing a novel class of protein therapeutics (biologics) aimed atpreventing and treating lethal Gram-negative bacterial infections associated primarily with the hospital setting.

Q&A

What is Lostam BioPharmaceuticals' primary focus?
Lostam BioPharmaceuticals is developing a novel class of protein therapeutics (biologics) aimed at preventing and treating lethal Gram-negative bacterial infections, primarily those associated with hospital settings.
When was Lostam BioPharmaceuticals founded?
Lostam BioPharmaceuticals was founded in October 2009.
What is the current status of Lostam BioPharmaceuticals?
Lostam BioPharmaceuticals is currently inactive, as of August 2016.
Where is Lostam BioPharmaceuticals headquartered?
Lostam BioPharmaceuticals is headquartered in Nazareth, North District, Israel.
What is Lostam BioPharmaceuticals' employee count bucket?
Lostam BioPharmaceuticals has 500+ employees.
Who is the founder of Lostam BioPharmaceuticals?
Lewis F. Neville, PhD is the Founder, CEO & CTO of Lostam BioPharmaceuticals.
What is the primary sector of Lostam BioPharmaceuticals?
Lostam BioPharmaceuticals' primary sector is Health Tech & Life Sciences.
What is the current funding stage of Lostam BioPharmaceuticals?
Lostam BioPharmaceuticals is in the Pre-Funding stage.

Team · 1

Lewis F. Neville, PhD
Founder · Founder, CEO & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

biopharmaceuticalbacteriainfectionmedical-technologiestherapeuticsproteinsbiotechnologytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)